PURPOSETo assess trial-level surrogacy value for overall survival (OS) of the pathologic complete response (pCR) and invasive disease-free survival (iDFS) in randomized clinical trials (RCTs) for early breast cancer (BC).METHODSIndividual patient data of …
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
Among patients with large B-cell lymphoma progressing after CD19-directed CAR T-cell therapy, treatment with CD22-Directed CAR T-cells provided durable remissions and long-term survival after 3…
Arce-Gallego et al. integrate next-generation sequencing with a RAD51 immunofluorescence assay to assess HRR function in advanced prostate cancer. They link RAD51-IF scores to mutations in…
Healio will present its fourth annual Disruptive Innovators Awards for oncology/hematology this spring.Individuals who have changed the face of the specialty and pushed the status…
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The Senate Finance Committee voted today in favor of Robert F. Kennedy (RFK) Jr.’s nomination for Secretary of the Department of Health and Human Services,…
Leveraging synthetic lethal approaches in lung cancer with new targets and agents may be a promising avenue of investigation.
Use Muck Rack to find journalists, get press for your story, monitor the news and report on the impact of your PR. Journalists can build…
Emma Searle, PhD, discusses bleximenib in combination with chemotherapy to treat patients with acute myeloid leukemia (AML).
You are invited to the free education event, Updates in Bladder and Urinary Tract Cancers for Patients and their Loved Ones, hosted by Fred Hutch…
